AI Terminal
Photocure ASA
Report Publication Announcement • Apr 5, 2024
3714_rns_2024-04-05_77a4ab77-0237-4d97-9720-1c14678af934.pdf
Report Publication Announcement
Open in ViewerOpens in native device viewer
Photocure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
OSLO, Norway, April 5, 2024 – Photocure ASA (OSE: PHO), The Bladder Cancer Company, announces that President and Chief Executive Officer, Dan Schneider will present a corporate overview and host 1-on-1 meetings with investors at the 23rd Annual Needham Healthcare Conference being held virtually April 8-11, 2024.
Presentation Details:
Date: April 11, 2024
Time: 10:15am ET (4:15pm CET)
Webcast Link: http://wsw.com/webcast/needham117/pho.ol/2531984
About the Needham Healthcare Conference
The 23rd Annual Needham Virtual Healthcare Conference will feature leading public and private companies in the Biotechnology, Specialty Pharmaceuticals, Medical Technology, and Diagnostics sectors.
About Photocure ASA
Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com, www.cysview.com
For further information, please contact:
Dan Schneider President and CEO Photocure ASA Email: [email protected] Erik Dahl CFO Photocure ASA Tel: +4745055000 Email: [email protected]
David Moskowitz Vice President, Investor Relations Photocure ASA Tel: +1 202 280 0888 Email: [email protected]
Media and IR enquiries:
Geir Bjørlo Corporate Communications (Norway) Tel: +47 91540000 Email: [email protected]